Colchicine is an alkaloid extracted from the bulb of colchicum. This medicine is used to treat acute attacks of gouty arthritis and prevent acute exacerbation of recurrent gouty arthritis.
Colchicine is a highly effective drug for the treatment of acute gout, but 50% to 80% of patients taking colchicine have had gastrointestinal side effects before the onset of gout, which has affected the growth of the colchicine market.
Colchicine has been FDA approved for use in combination with probenicid for gout since 1982. As part of a program to promote safety studies for grandfathered meds, in 2009 the FDA approved its use for acute gout flares, gout prophylaxis, and Familial Mediterranean Fever. It is also used off-label for pseudogout, Behcet’s disease, pericarditis, and primary biliary cirrhosis.
The global Colchicine market was valued at 920 million US$ in 2018 and will reach 1270 million US$ by the end of 2025, growing at a CAGR of 4.0% during 2019-2025.
This report focuses on Colchicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Colchicine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Colchicine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Colchicine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Takeda Pharmaceuticals
Hikma
Cipla
Wockhardt
West-Ward
Excellium Pharmaceutical
Rhea Pharmaceutical
Medinova
Odan Laboratories
Prasco
Kunming Pharmaceutical
Yunnan Plant Medicine
Xishuangbanna Pharmaceutical
Guangdong Pedi
Yunnan Shan State
Tonghua Limin
Beijing Jialin Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tablet
Oral Solution
Segment by Application
Acute Gout
Chronic Gout
Other Conditions
Table of Contents
Executive Summary
1 Industry Overview of Colchicine
1.1 Definition of Colchicine
1.2 Colchicine Segment by Type
1.2.1 Global Colchicine Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Colchicine Segment by Applications
1.3.1 Global Colchicine Consumption Comparison by Applications (2014-2025)
1.3.2 Acute Gout
1.3.3 Chronic Gout
1.3.4 Other Conditions
1.4 Global Colchicine Overall Market
1.4.1 Global Colchicine Revenue (2014-2025)
1.4.2 Global Colchicine Production (2014-2025)
1.4.3 North America Colchicine Status and Prospect (2014-2025)
1.4.4 Europe Colchicine Status and Prospect (2014-2025)
1.4.5 China Colchicine Status and Prospect (2014-2025)
1.4.6 Japan Colchicine Status and Prospect (2014-2025)
1.4.7 Southeast Asia Colchicine Status and Prospect (2014-2025)
1.4.8 India Colchicine Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Colchicine
2.3 Manufacturing Process Analysis of Colchicine
2.4 Industry Chain Structure of Colchicine
3 Development and Manufacturing Plants Analysis of Colchicine
3.1 Capacity and Commercial Production Date
3.2 Global Colchicine Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Colchicine
Summary: Get latest Market Research Reports on Colchicine. Industry analysis & Market Report on Colchicine is a syndicated market report, published as Global Colchicine Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Colchicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.